4.68
price down icon0.85%   -0.04
 
loading
전일 마감가:
$4.72
열려 있는:
$4.63
하루 거래량:
2,754
Relative Volume:
0.21
시가총액:
$32.75M
수익:
$598.00K
순이익/손실:
$-21.81M
주가수익비율:
-1.1359
EPS:
-4.12
순현금흐름:
$-16.66M
1주 성능:
-0.43%
1개월 성능:
+7.09%
6개월 성능:
-6.96%
1년 성능:
-39.06%
1일 변동 폭
Value
$4.55
$4.71
1주일 범위
Value
$4.55
$4.90
52주 변동 폭
Value
$4.07
$8.48

Pluri Inc Stock (PLUR) Company Profile

Name
명칭
Pluri Inc
Name
전화
972-74-710-7171
Name
주소
MATAM ADVANCED TECHNOLOGY PARK, HAIFA
Name
직원
118
Name
트위터
Name
다음 수익 날짜
2024-11-11
Name
최신 SEC 제출 서류
Name
PLUR's Discussions on Twitter

PLUR을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
PLUR
Pluri Inc
4.68 32.75M 598.00K -21.81M -16.66M -4.12
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
495.42 127.22B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
689.50 75.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
591.45 35.94B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
242.43 31.38B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
249.84 26.84B 3.32B -860.46M -1.04B -8.32

Pluri Inc 주식(PLUR)의 최신 뉴스

pulisher
Mar 12, 2025

Using cell science to fight nuclear weapons: How is Pluri revolutionizing health and food tech? - The Jerusalem Post

Mar 12, 2025
pulisher
Mar 11, 2025

Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Forecast: Ke... - WhaTech

Mar 11, 2025
pulisher
Mar 05, 2025

Pluri Inc. partners with Hemafund for radiation emergency response By Investing.com - Investing.com Canada

Mar 05, 2025
pulisher
Mar 05, 2025

Pluri Inc. and Hemafund partner for radiation emergency pre By Investing.com - Investing.com Canada

Mar 05, 2025
pulisher
Mar 05, 2025

Pluri signs deal to help Ukraine's radiation emergency preparedness - The Pharma Letter

Mar 05, 2025
pulisher
Mar 05, 2025

Pluri, Hemafund Sign Exclusive Collaboration Deal on Potential Radiation Treatment; Shares Rise - Marketscreener.com

Mar 05, 2025
pulisher
Mar 05, 2025

Pluri Inc. and Hemafund partner for radiation emergency pre - Investing.com India

Mar 05, 2025
pulisher
Mar 05, 2025

Pluri Inc. partners with Hemafund for radiation emergency response - Investing.com

Mar 05, 2025
pulisher
Mar 05, 2025

Pluri announces exclusive collaboration agreement with Hemafund - TipRanks

Mar 05, 2025
pulisher
Mar 05, 2025

Pluri Announces Exclusive Collaboration Agreement with Hemafund to Enhance Ukraine's Radiation Emergency Preparedness - The Manila Times

Mar 05, 2025
pulisher
Mar 05, 2025

Can Pluri's Radiation Therapy Save Lives in Ukraine's Nuclear Crisis? - StockTitan

Mar 05, 2025
pulisher
Feb 22, 2025

Head-To-Head Survey: Pluri (NASDAQ:PLUR) & Kyverna Therapeutics (NASDAQ:KYTX) - Defense World

Feb 22, 2025
pulisher
Feb 19, 2025

EAF and Buhler announce collaboration - TipRanks

Feb 19, 2025
pulisher
Feb 19, 2025

Can This New Technology Finally Make Lab-Grown Meat Affordable? Ever After Foods Says Yes - StockTitan

Feb 19, 2025
pulisher
Feb 17, 2025

Pluri Announces Strategic Merger to Enhance Market Position - TipRanks

Feb 17, 2025
pulisher
Feb 12, 2025

Pluri Proposes Extension of Convertible Bond Maturity to Key Investor - TipRanks

Feb 12, 2025
pulisher
Feb 11, 2025

Pluri: Fiscal Q2 Earnings Snapshot - CT Insider

Feb 11, 2025
pulisher
Feb 11, 2025

Pluri: Fiscal Q2 Earnings Snapshot -February 11, 2025 at 05:38 pm EST - Marketscreener.com

Feb 11, 2025
pulisher
Feb 11, 2025

Pluri Inc. Faces Financial Challenges Amid Continued Innovation - TipRanks

Feb 11, 2025
pulisher
Feb 11, 2025

Pluri Inc. SEC 10-Q Report - TradingView

Feb 11, 2025
pulisher
Feb 11, 2025

Pluristyx Enables Safer, Universal Cell Therapy Solutions with Newly Issued U.S. Patent for iACT Stealth™ Technology - Business Wire

Feb 11, 2025
pulisher
Feb 11, 2025

Pluri Ltd. Strengthens Financial Position Through Capital Raising - TipRanks

Feb 11, 2025
pulisher
Feb 06, 2025

Romanian Fintech Company Pluridio is Expanding its Global Presence by Opening a Subsidiary in the UK - PR Newswire

Feb 06, 2025
pulisher
Feb 05, 2025

Plurilock Security (CVE:PLUR) Trading Up 4% – Should You Buy? - Defense World

Feb 05, 2025
pulisher
Feb 05, 2025

Pluri (NASDAQ:PLUR) Trading Down 4.4% – Time to Sell? - Defense World

Feb 05, 2025
pulisher
Feb 04, 2025

Pluri secures additional $3.5 million investment - MSN

Feb 04, 2025
pulisher
Feb 04, 2025

Pluri Secures Additional $3.5 Million Investment from Major Shareholder at Premium to Market, Bringing Total Recent Financings to $10 Million - The Manila Times

Feb 04, 2025
pulisher
Feb 01, 2025

The Month In Cultivated Meat: January - substack.com

Feb 01, 2025
pulisher
Jan 31, 2025

Pluri Inc. Announces Appointment of Alejandro Weinstein to Board of Directors -January 23, 2025 at 07:15 am EST - Marketscreener.com

Jan 31, 2025
pulisher
Jan 30, 2025

Liberation labs raises $50.5m: The Week in AgriFoodTech - AgFunderNews

Jan 30, 2025
pulisher
Jan 29, 2025

Pluri Strengthens Leadership Amid Strategic Board Appointment - TipRanks

Jan 29, 2025
pulisher
Jan 28, 2025

Adipose-Derived Stem Cell Market to Reach $3013.9 Million by 2030. - openPR

Jan 28, 2025
pulisher
Jan 24, 2025

Pluri Inc. granted extension to regain Nasdaq compliance - MSN

Jan 24, 2025
pulisher
Jan 24, 2025

Pluri gets $6.5M investment from Alejandro Weinstein, enters cacao market - Yahoo Finance

Jan 24, 2025
pulisher
Jan 23, 2025

BeZero closes $32m round: The Week in AgriFoodTech - AgFunderNews

Jan 23, 2025
pulisher
Jan 23, 2025

Pluri Secures $6.5 Million Investment and Acquires Majority Stake in Cell-Based Cacao Producer Kokomodovegconomist - vegconomist - the vegan business magazine

Jan 23, 2025
pulisher
Jan 23, 2025

Pluri Secures $6.5 Million Strategic Investment at Premium to Market, Enters Cacao Market Through Acquisition - The Manila Times

Jan 23, 2025
pulisher
Jan 23, 2025

Pluri Secures $6.5M Premium Investment, Acquires Majority Stake in Cultivated Cacao Pioneer - StockTitan

Jan 23, 2025
pulisher
Jan 16, 2025

Comparing Adverum Biotechnologies (NASDAQ:ADVM) & Pluri (NASDAQ:PLUR) - Defense World

Jan 16, 2025
pulisher
Jan 13, 2025

Anavex Life Sciences (NASDAQ:AVXL) vs. Pluri (NASDAQ:PLUR) Critical Comparison - Defense World

Jan 13, 2025
pulisher
Jan 09, 2025

BCLI: Plans Coming Together for Phase 3b Trial of NurOwn® in ALS… - MSN

Jan 09, 2025
pulisher
Jan 07, 2025

Pluristyx Announces Immediate Availability of GMP-Compliant PSXi013 iPSC Line for Advanced Therapy Development - Business Wire

Jan 07, 2025
pulisher
Jan 07, 2025

Head to Head Review: Pluri (NASDAQ:PLUR) & Gilead Sciences (NASDAQ:GILD) - Defense World

Jan 07, 2025
pulisher
Dec 31, 2024

Pluristem stock touches 52-week low at $4.11 amid market challenges - Investing.com India

Dec 31, 2024
pulisher
Dec 31, 2024

Pluristem stock touches 52-week low at $4.11 amid market challenges By Investing.com - Investing.com South Africa

Dec 31, 2024

Pluri Inc (PLUR) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$35.01
price up icon 3.70%
$307.09
price up icon 0.88%
$32.85
price up icon 1.20%
$19.91
price up icon 7.62%
$100.31
price up icon 1.95%
biotechnology ONC
$249.84
price up icon 1.68%
자본화:     |  볼륨(24시간):